{
"info": {
"nct_id": "NCT03575520",
"official_title": "A Phase II Study to Evaluate the Safety and Efficacy of Pegteograstim in Korean Breast Cancer Patients Receiving Dose-dense Doxorubicin/Cyclophosphamide",
"inclusion_criteria": "* Histological or cytological diagnosis of a primary breast cancer (stage I-III)\n* Age > 18 years of age and Age < 66 years of age\n* Eastern Cooperative Oncology Group (ECOG) performance status score 0 - 1\n* Patients who have plan to receive neoadjuvant or adjuvant dose-dense AC chemotherapy\n* Adequate organ functions\n\n 1. ANC ≥1500 cells/mm3\n 2. PLT ≥100,000 cells/mm3\n 3. CCr ≥50 mL/min, or Serum Cr <1.5 x (upper limit of normal, ULN)\n 4. Total bilirubin ≤1.5 x ULN\n 5. AST (SGOT) ≤2.5 x ULN\n 6. ALT (SGPT) ≤2.5 x ULN\nHealthy volunteers allowed\nMust be FEMALE\nMust have minimum age of 19 Years\nMust have maximum age of 65 Years",
"exclusion_criteria": "* Previous chemotherapy history\n* Previous bone marrow transplantation history\n* Sickle cell anemia\n* Radiation therapy within 4 weeks from enrollment\n* Previous pegfilgrastim, filgrastim or other colony-stimulating factor treatment within 4 weeks from enrollment\n* Clinically significant systemic illness (serious infection, liver, kidney, heart disease)\n* Pregnant, breast feeding women",
"miscellaneous_criteria": ""
},
"inclusion_lines": [
{
"line": "* Histological or cytological diagnosis of a primary breast cancer (stage I-III)",
"criterions": [
{
"exact_snippets": "Histological or cytological diagnosis of a primary breast cancer",
"criterion": "primary breast cancer",
"requirements": [
{
"requirement_type": "diagnosis method",
"expected_value": [
"histological",
"cytological"
]
}
]
},
{
"exact_snippets": "primary breast cancer (stage I-III)",
"criterion": "primary breast cancer stage",
"requirements": [
{
"requirement_type": "stage",
"expected_value": {
"comparisons": [
{
"operator": ">=",
"value": 1,
"unit": "stage"
},
{
"operator": "<=",
"value": 3,
"unit": "stage"
}
]
}
}
]
}
]
},
{
"line": "* Age > 18 years of age and Age < 66 years of age",
"criterions": [
{
"exact_snippets": "Age > 18 years of age",
"criterion": "age",
"requirements": [
{
"requirement_type": "age",
"expected_value": {
"operator": ">",
"value": 18,
"unit": "years"
}
}
]
},
{
"exact_snippets": "Age < 66 years of age",
"criterion": "age",
"requirements": [
{
"requirement_type": "age",
"expected_value": {
"operator": "<",
"value": 66,
"unit": "years"
}
}
]
}
]
},
{
"line": "* Eastern Cooperative Oncology Group (ECOG) performance status score 0 - 1",
"criterions": [
{
"exact_snippets": "Eastern Cooperative Oncology Group (ECOG) performance status score 0 - 1",
"criterion": "ECOG performance status score",
"requirements": [
{
"requirement_type": "range",
"expected_value": {
"comparisons": [
{
"operator": ">=",
"value": 0,
"unit": "N/A"
},
{
"operator": "<=",
"value": 1,
"unit": "N/A"
}
]
}
}
]
}
]
},
{
"line": "* Patients who have plan to receive neoadjuvant or adjuvant dose-dense AC chemotherapy",
"criterions": [
{
"exact_snippets": "plan to receive neoadjuvant or adjuvant dose-dense AC chemotherapy",
"criterion": "chemotherapy plan",
"requirements": [
{
"requirement_type": "type",
"expected_value": [
"neoadjuvant",
"adjuvant"
]
},
{
"requirement_type": "regimen",
"expected_value": "dose-dense AC"
}
]
}
]
},
{
"line": "* Adequate organ functions",
"criterions": [
{
"exact_snippets": "Adequate organ functions",
"criterion": "organ functions",
"requirements": [
{
"requirement_type": "adequacy",
"expected_value": true
}
]
}
]
},
{
"line": "1. ANC ≥1500 cells/mm3",
"criterions": [
{
"exact_snippets": "ANC ≥1500 cells/mm3",
"criterion": "ANC",
"requirements": [
{
"requirement_type": "quantity",
"expected_value": {
"operator": ">=",
"value": 1500,
"unit": "cells/mm3"
}
}
]
}
]
},
{
"line": "2. PLT ≥100,000 cells/mm3",
"criterions": [
{
"exact_snippets": "PLT ≥100,000 cells/mm3",
"criterion": "platelet count",
"requirements": [
{
"requirement_type": "quantity",
"expected_value": {
"operator": ">=",
"value": 100000,
"unit": "cells/mm3"
}
}
]
}
]
},
{
"line": "3. CCr ≥50 mL/min, or Serum Cr <1.5 x (upper limit of normal, ULN)",
"criterions": [
{
"exact_snippets": "CCr ≥50 mL/min",
"criterion": "creatinine clearance (CCr)",
"requirements": [
{
"requirement_type": "value",
"expected_value": {
"operator": ">=",
"value": 50,
"unit": "mL/min"
}
}
]
},
{
"exact_snippets": "Serum Cr <1.5 x (upper limit of normal, ULN)",
"criterion": "serum creatinine (Serum Cr)",
"requirements": [
{
"requirement_type": "value",
"expected_value": {
"operator": "<",
"value": 1.5,
"unit": "x ULN"
}
}
]
}
]
},
{
"line": "4. Total bilirubin ≤1.5 x ULN",
"criterions": [
{
"exact_snippets": "Total bilirubin ≤1.5 x ULN",
"criterion": "total bilirubin",
"requirements": [
{
"requirement_type": "level",
"expected_value": {
"operator": "<=",
"value": 1.5,
"unit": "x ULN"
}
}
]
}
]
},
{
"line": "5. AST (SGOT) ≤2.5 x ULN",
"criterions": [
{
"exact_snippets": "AST (SGOT) ≤2.5 x ULN",
"criterion": "AST (SGOT) level",
"requirements": [
{
"requirement_type": "value",
"expected_value": {
"operator": "<=",
"value": 2.5,
"unit": "x ULN"
}
}
]
}
]
},
{
"line": "6. ALT (SGPT) ≤2.5 x ULN",
"criterions": [
{
"exact_snippets": "ALT (SGPT) ≤2.5 x ULN",
"criterion": "ALT (SGPT) level",
"requirements": [
{
"requirement_type": "comparison",
"expected_value": {
"operator": "<=",
"value": 2.5,
"unit": "x ULN"
}
}
]
}
]
},
{
"line": "Healthy volunteers allowed",
"criterions": [
{
"exact_snippets": "Healthy volunteers allowed",
"criterion": "volunteer health status",
"requirements": [
{
"requirement_type": "status",
"expected_value": "healthy"
}
]
}
]
},
{
"line": "Must be FEMALE",
"criterions": [
{
"exact_snippets": "Must be FEMALE",
"criterion": "gender",
"requirements": [
{
"requirement_type": "N/A",
"expected_value": "female"
}
]
}
]
},
{
"line": "Must have minimum age of 19 Years",
"criterions": [
{
"exact_snippets": "minimum age of 19 Years",
"criterion": "age",
"requirements": [
{
"requirement_type": "minimum",
"expected_value": {
"operator": ">=",
"value": 19,
"unit": "Years"
}
}
]
}
]
},
{
"line": "Must have maximum age of 65 Years",
"criterions": [
{
"exact_snippets": "maximum age of 65 Years",
"criterion": "age",
"requirements": [
{
"requirement_type": "maximum",
"expected_value": {
"operator": "<=",
"value": 65,
"unit": "Years"
}
}
]
}
]
}
],
"exclusion_lines": [
{
"line": "* Previous chemotherapy history",
"criterions": [
{
"exact_snippets": "Previous chemotherapy history",
"criterion": "chemotherapy history",
"requirements": [
{
"requirement_type": "presence",
"expected_value": true
}
]
}
]
},
{
"line": "* Previous bone marrow transplantation history",
"criterions": [
{
"exact_snippets": "Previous bone marrow transplantation history",
"criterion": "bone marrow transplantation",
"requirements": [
{
"requirement_type": "history",
"expected_value": true
}
]
}
]
},
{
"line": "* Sickle cell anemia",
"criterions": [
{
"exact_snippets": "Sickle cell anemia",
"criterion": "sickle cell anemia",
"requirements": [
{
"requirement_type": "presence",
"expected_value": true
}
]
}
]
},
{
"line": "* Radiation therapy within 4 weeks from enrollment",
"criterions": [
{
"exact_snippets": "Radiation therapy within 4 weeks from enrollment",
"criterion": "radiation therapy",
"requirements": [
{
"requirement_type": "time since last treatment",
"expected_value": {
"operator": "<=",
"value": 4,
"unit": "weeks"
}
}
]
}
]
},
{
"line": "* Previous pegfilgrastim, filgrastim or other colony-stimulating factor treatment within 4 weeks from enrollment",
"criterions": [
{
"exact_snippets": "Previous pegfilgrastim, filgrastim or other colony-stimulating factor treatment within 4 weeks from enrollment",
"criterion": "colony-stimulating factor treatment",
"requirements": [
{
"requirement_type": "time since last treatment",
"expected_value": {
"operator": "<=",
"value": 4,
"unit": "weeks"
}
}
]
}
]
},
{
"line": "* Clinically significant systemic illness (serious infection, liver, kidney, heart disease)",
"criterions": [
{
"exact_snippets": "Clinically significant systemic illness (serious infection",
"criterion": "systemic illness",
"requirements": [
{
"requirement_type": "severity",
"expected_value": "clinically significant"
}
]
},
{
"exact_snippets": "liver",
"criterion": "liver disease",
"requirements": [
{
"requirement_type": "presence",
"expected_value": true
}
]
},
{
"exact_snippets": "kidney",
"criterion": "kidney disease",
"requirements": [
{
"requirement_type": "presence",
"expected_value": true
}
]
},
{
"exact_snippets": "heart disease",
"criterion": "heart disease",
"requirements": [
{
"requirement_type": "presence",
"expected_value": true
}
]
}
]
},
{
"line": "* Pregnant, breast feeding women",
"criterions": [
{
"exact_snippets": "Pregnant",
"criterion": "pregnancy",
"requirements": [
{
"requirement_type": "presence",
"expected_value": false
}
]
},
{
"exact_snippets": "breast feeding",
"criterion": "breastfeeding",
"requirements": [
{
"requirement_type": "presence",
"expected_value": false
}
]
}
]
}
],
"miscellaneous_lines": [],
"failed_inclusion": [],
"failed_exclusion": [],
"failed_miscellaneous": []
}